Indiana University Employs Cloud Computing, AI for Precision Medicine

IU is employing these technologies to target certain cancers, such as multiple myeloma, triple-negative breast cancer, and pediatric sarcomas, and chronic diseases, such as diabetes and Alzheimer’s, explained Peter Embi, MD, president and CEO of Regenstrief Institute, which is a medical research organization affiliated with IU and Purdue University. IU decided to partner with LifeOmic, which provides a secure cloud service for the long-term storage, retrieval, analysis, and clinical use of medical research data. IU has a 1.5 percent ownership stake in LifeOmic, which was founded by Don Brown, an IU alumnus. In addition, IU and other universities, through their Indiana Clinical Translational Sciences Institute (CTSI), are working with LifeOmic to provide the LIFE Extend app to enable Indiana residents to live a healthy lifestyle. CTSI is a research partnership among IU, Purdue University, and the University of Notre Dame. The LIFE Extend app includes the option for users to participate in the All IN for Health program, which links Indiana residents with opportunities to improve their health and participate in research and clinical studies. Indiana CTSI and LifeOmic have set a goal of engaging more than 100,000 residents in the All IN for Health program.